M. Boyd
Profile
M.
Cantey Boyd served as a Director at Aquinox Pharmaceuticals, Inc. and Neoleukin Therapeutics, Inc. She also worked as an Independent Director at Neoleukin Therapeutics, Inc. and as a Principal at Baker Bros.
Advisors LP.
Boyd completed her undergraduate degree at Brown University.
Former positions of M. Boyd
Companies | Position | End |
---|---|---|
NEUROGENE INC. | Director/Board Member | - |
Neoleukin Therapeutics, Inc. /old/
Neoleukin Therapeutics, Inc. /old/ Pharmaceuticals: MajorHealth Technology Neoleukin Therapeutics, Inc. operates as a biopharmaceutical firm utilizing sophisticated computational methods. develop and designs de novo protein therapeutics. The company was is headquartered in Seattle, WA. | Director/Board Member | - |
Aquinox Pharmaceuticals, Inc.
Aquinox Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops targeted therapeutics for inflammation and immuno-oncology. It also focuses on anti-inflammatory product candidates targeting SHIP1, which is a key regulator of an important cellular signaling pathway in immune cells, known as the PI3K pathway. The company was founded by Raymond J. Andersen, David J. Main, Low Fung Mui, Christopher John Ong, and Gerald Krystal on December 26, 2003 and is headquartered in Vancouver, Canada. | Director/Board Member | - |
Baker Bros. Advisors LP
Baker Bros. Advisors LP Investment ManagersFinance Baker Bros. Advisors LP (BBA) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by Julian Baker and Felix Baker in 2000 and do-business-as Baker Brothers Investments. BBA serves as a discretionary investment advisor to pooled investment vehicles operating as private investment funds and to a managed account. | Analyst-Equity | - |
Training of M. Boyd
Brown University | Undergraduate Degree |
Experiences
Positions held
Linked companies
Private companies | 4 |
---|---|
Baker Bros. Advisors LP
Baker Bros. Advisors LP Investment ManagersFinance Baker Bros. Advisors LP (BBA) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by Julian Baker and Felix Baker in 2000 and do-business-as Baker Brothers Investments. BBA serves as a discretionary investment advisor to pooled investment vehicles operating as private investment funds and to a managed account. | Finance |
Aquinox Pharmaceuticals, Inc.
Aquinox Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops targeted therapeutics for inflammation and immuno-oncology. It also focuses on anti-inflammatory product candidates targeting SHIP1, which is a key regulator of an important cellular signaling pathway in immune cells, known as the PI3K pathway. The company was founded by Raymond J. Andersen, David J. Main, Low Fung Mui, Christopher John Ong, and Gerald Krystal on December 26, 2003 and is headquartered in Vancouver, Canada. | Health Technology |
Neoleukin Therapeutics, Inc. /old/
Neoleukin Therapeutics, Inc. /old/ Pharmaceuticals: MajorHealth Technology Neoleukin Therapeutics, Inc. operates as a biopharmaceutical firm utilizing sophisticated computational methods. develop and designs de novo protein therapeutics. The company was is headquartered in Seattle, WA. | Health Technology |
Neoleukin Therapeutics, Inc.
Neoleukin Therapeutics, Inc. BiotechnologyHealth Technology Neoleukin Therapeutics, Inc. operates as a biopharmaceutical company, which computational methods to design de novo protein therapeutics. The firm address significant medical needs in oncology, inflammation, and autoimmunity. Its lead product candidate, NL-201, is a combined IL-2 and IL-15 agonist designed to eliminate alpha receptor binding. The company was founded by Daniel-Adriano Silva, Carl Walkey, and Umut Ulge in December 2003 and is headquartered in Seattle, WA. | Health Technology |
- Stock Market
- Insiders
- M. Boyd